Literature DB >> 15230845

Performance after partial arytenoidectomy without mucosal closure in 27 Thoroughbred racehorses.

Amy J Barnes1, Donnie E Slone, Tim M Lynch.   

Abstract

OBJECTIVE: To examine the effect of partial arytenoidectomy without mucosal closure on postoperative racing performance and long-term complications in Thoroughbred racehorses treated for laryngeal hemiplegia, arytenoid chondropathy, or failed laryngoplasty. STUDY
DESIGN: Retrospective study. ANIMALS: Twenty-seven Thoroughbred racehorses.
METHODS: Medical records of Thoroughbred racehorses that had partial arytenoidectomy without mucosal closure between 1992 and 2002 were reviewed. Horses were divided into groups: horses that had not raced (Group 1) and those that had raced (Group 2) before surgery. Lifetime race records were compared between groups. A standard starts index (SSI) and performance index (PI) were used for Groups 1 and 2, respectively, to objectively evaluate each horse's postoperative performance. Telephone interviews of owners and trainers were used for subjective performance evaluation and to determine prevalence of long-term complications.
RESULTS: Eleven (61%) Group 1 and 7 (78%) Group 2 horses raced and earned money after surgery. All Group 1 horses that raced performed at a level lower than the national average. Only 1 Group 2 horse had an improved PI score postoperatively.
CONCLUSIONS: Thoroughbred racehorses have a fair prognosis for racing successfully after partial arytenoidectomy without mucosal closure. CLINICAL RELEVANCE: This technique may be a practical alternative to primary mucosal closure, would decrease surgical time, and avoid some problems reported with primary mucosal closure.

Entities:  

Mesh:

Year:  2004        PMID: 15230845     DOI: 10.1111/j.1532-950X.2004.04058.x

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  1 in total

1.  Computed tomography-guided tissue engineering of upper airway cartilage.

Authors:  Bryan N Brown; Nicholas J Siebenlist; Jonathan Cheetham; Norm G Ducharme; Jeremy J Rawlinson; Lawrence J Bonassar
Journal:  Tissue Eng Part C Methods       Date:  2013-12-11       Impact factor: 3.056

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.